Doshi S.M. Shah P. Lei X. Lahoti A. Salahudeen A.K.

Hyponatremia in hospitalized cancer patients and its impact on clinical outcomes.

Am J Kidney Dis. 59: 222-228

Electrolyte and acid-base disorders in cancer patients and its impact on clinical outcomes: evidence from a real-world study in China.

Ren Fail. 42: 234-243Penttilä P. Bono P. Peltola K. Donskov F.

Hyponatremia associates with poor outcome in metastatic renal cell carcinoma patients treated with everolimus: prognostic impact.

Acta Oncol. 57: 1580-1585

The occurrence of hyponatremia and its importance as a prognostic factor in a cross-section of cancer patients.

BMC Cancer. 16: 1-9

Hypernatremia at admission predicts poor survival in patients with terminal cancer: a retrospective cohort study.

BMC Palliat Care. 19: 1-7Hansen O. Sørensen P. Hansen K.H.

The occurrence of hyponatremia in SCLC and the influence on prognosis.

Lung Cancer. 68: 111-114Sandfeld-Paulsen B. Aggerholm-Pedersen N. Winther-Larsen A.

Hyponatremia as a prognostic factor in non-small cell lung cancer: a systematic review and meta-analysis.

Transl Lung Cancer Res. 10: 651-661Sandfeld-Paulsen B. Aggerholm-Pedersen N. Winther-Larsen A.

Hyponatremia in lung cancer: incidence and prognostic value in a Danish population-based cohort study.

Lung Cancer. 153: 42-48

Hyponatremia in patients with cancer.

Curr Opin Nephrol Hypertens. 28: 433-440Workeneh B.T. Jhaveri K.D. Rondon-Berrios H.

Hyponatremia in the cancer patient.

Kidney Int. 98: 870-882

Clinically significant pseudohyponatremia.

Am J Hematol. 81: 558-559

Pseudohyponatremia in multiple myeloma.

South Med J. 86: 251-252Katrangi W. Baumann N.A. Nett R.C. Karon B.S. Block D.R.

Prevalence of clinically significant differences in sodium measurements due to abnormal protein concentrations using an indirect ion-selective electrode method.

J Appl Lab Med. 4: 427-432Kim A.H. Keltz M.D. Arici A. Rosenberg M. Olive D.L.

Dilutional hyponatremia during hysteroscopic myomectomy with sorbitol-mannitol distention medium.

J Am Assoc Gynecol Laparosc. 2: 237-242

Intravenous immunoglobulins: in-depth review of excipients and acute kidney injury risk.

Am J Nephrol. 38: 275-284

Acute renal failure, translocational hyponatremia and hyperkalemia following intravenous immunoglobulin therapy.

Nephron Clin Pract. 106: c143-c148García-Morales E.J. Cariappa R. Parvin C.A. Scott M.G. Diringer M.N.

Osmole gap in neurologic-neurosurgical intensive care unit: its normal value, calculation, and relationship with mannitol serum concentrations.

Crit Care Med. 32: 986-991Fanous A.A. Tick R.C. Gu E.Y. Fenstermaker R.A.

Life-threatening mannitol-induced hyperkalemia in neurosurgical patients.

World Neurosurg. 91: e672.e5-e672.e9Ruiz J. Ecker L. Ochoa T.J. Pantenburg B.

Use of commercially available oral rehydration solutions in Lima, Peru.

Am J Trop Med Hyg. 86: 922-924

Acute kidney injury and electrolyte abnormalities after Chimeric Antigen receptor T-cell (CAR-T) therapy for diffuse large B-cell lymphoma.

Am J Kidney Dis. 76: 63-71Uppal N.N. Wanchoo R. Barnett R. Sinha A. Jhaveri K.D.

Hyponatremia in a patient with cancer.

Am J Kidney Dis. 75: A15-A18

Cardio-oncology: protecting the heart from curative breast cancer treatment.

Gland Surg. 7: 350-365

Liver injury induced by anticancer chemotherapy and radiation therapy.

Int J Hepatol. 2013: 1-8

Incidence of hyponatremia in patients with indwelling peritoneal catheters for drainage of malignant ascites.

JAMA Netw Open. 3e2017859Schwartz W.B. Bennett W. Curelop S. Bartter F.C.

A syndrome of renal sodium loss and hyponatremia probably resulting from inappropriate secretion of antidiuretic hormone.

Am J Med. 23: 529-542

The syndrome of inappropriate secretion of antidiuretic hormone (SIADH) in small-cell lung cancer.

J Clin Oncol. 4: 1191-1198

Hyponatremia and perioperative complications in patients with head and neck squamous cell carcinoma: hyponatremia and perioperative complications in HNSCC.

Head Neck. 38: E1370-E1374

Diagnosis, evaluation, and treatment of hyponatremia: Expert Panel recommendations.

Am J Med. 126: S1-S42Sood L. Sterns R.H. Hix J.K. Silver S.M. Chen L.

Hypertonic saline and desmopressin: a simple strategy for safe correction of severe hyponatremia.

Am J Kidney Dis. 61: 571-578

Urea for the treatment of hyponatremia.

Clin J Am Soc Nephrol. 13: 1627-1632Lehrich R.W. Ortiz-Melo D.I. Patel M.B. Greenberg A.

Role of Vaptans in the management of hyponatremia.

Am J Kidney Dis. 62: 364-376Neftel K.A. Stahel R. Muller O.

Case 9-1982: malignant lymphoma.

N Engl J Med. 307 (): 377Cancer G. Gipstein R.M. Boyle J.D.

Hypernatremia complicating prolonged mannitol diuresis.

N Engl J Med. 272: 1116-1117

Hypernatremia, Azotemia, and dehydration due to high-protein tube feeding.

Ann Intern Med. 68: 778-791

Pituitary metastases: presentation and outcomes from a pituitary center over the last decade.

Pituitary. 23: 258-265

Central diabetes insipidus: a previously unreported side effect of temozolomide.

J Clin Endocrinol Metab. 98: 3926-3931Fung E. Anand S. Bhalla V.

Pemetrexed-induced nephrogenic diabetes insipidus.

Am J Kidney Dis. 68: 628-632

Rate of correction of hypernatremia and health outcomes in critically ill patients.

Clin J Am Soc Nephrol. 14: 656-663

Evidence for managing hypernatremia: is it just hyponatremia in reverse?.

Clin J Am Soc Nephrol. 14: 645-647Seay N.W. Lehrich R.W. Greenberg A.

Diagnosis and management of disorders of body Tonicity—hyponatremia and hypernatremia: core curriculum 2020.

Am J Kidney Dis. 75: 272-286Liamis G. Liberopoulos E. Barkas F. Elisaf M.

Spurious electrolyte disorders: a diagnostic challenge for clinicians.

Am J Nephrol. 38: 50-57

Hypokalemia in nonblastic chronic myelogenous leukemia.

Arch Intern Med. 141: 786-787Mehanna H. Nankivell P.C. Moledina J. Travis J.

Refeeding syndrome--awareness, prevention and management.

Head Neck Oncol. 1: 1-5

Laboratory tests to determine the cause of hypokalemia and paralysis.

Arch Intern Med. 164: 1561-1566Ledeganck K.J. Boulet G.A. Bogers J.J. Verpooten G.A. De Winter B.Y.

The TRPM6/EGF pathway is downregulated in a rat model of cisplatin nephrotoxicity.

PLoS One. 8e57016Herrmann S.M. Alexander M.P. Romero M.F. Zand L.

Renal tubular acidosis and immune checkpoint inhibitor therapy: an immune-related adverse event of PD-1 inhibitor-a report of 3 cases.

Kidney Med. 2: 657-662Anson D. Norton J. Chaucer B. Bansal S.

Ipilimumab- and nivolumab-induced colitis causing severe hypokalemia and QTc prolongation.

Case Rep Oncol Med. 2019: 7896749

The prevalence of hyperkalemia in the United States.

Curr Med Res Opin. 34: 971-978

Association of serum potassium with all-cause mortality in patients with and without heart failure, chronic kidney disease, and/or diabetes.

Am J Nephrol. 46: 213-221Rastegar A. Soleimani M. Rastergar A.

Hypokalaemia and hyperkalaemia.

Postgrad Med J. 77: 759-764Rabelink T.J. Koomans H.A. Hené R.J. Dorhout Mees E.J.

Early and late adjustment to potassium loading in humans.

Kidney Int. 38: 942-947

Management of hyperkalaemia in chronic kidney disease.

Nat Rev Nephrol. 10: 653-662

Adrenal insufficiency and other adrenal oncologic emergencies.

Emerg Med Clin North Am. 27: 271-282Ajlan A. Almufawez K.A. Albakr A. Katznelson L. Harsh G.R.

Adrenal axis insufficiency after endoscopic transsphenoidal resection of pituitary adenomas.

World Neurosurg. 112: e869-e875

Immune checkpoint inhibitor-associated primary adrenal insufficiency: WHO VigiBase report analysis.

Oncologist. 25: 696-701

Acute rhabdomyolysis as a complication of cytarabine chemotherapy for acute myeloid leukemia: case report and review of literature.

Am J Hematol. 70: 320-323

Severe rhabdomyolysis associated with pemetrexed-based chemotherapy.

Lancet Oncol. 7: 353Liewluck T. Kao J.C. Mauermann M.L.

PD-1 inhibitor-associated myopathies: emerging immune-mediated myopathies.

J Immunother. 41: 208-211

Myositis and neuromuscular side-effects induced by immune checkpoint inhibitors.

Eur J Cancer. 106: 12-23

Tumour lysis syndrome: new therapeutic strategies and classification.

Br J Haematol. 127: 3-11Webster A. Brady W. Morris F.

Recognising signs of danger: ECG changes resulting from an abnormal serum potassium concentration.

Emerg Med J. 19: 74-77